Flag of Sweden Flag of Spain Flag of Germany Flag of Great Britain

 

News

23 January 2017: BMC Pregnancy and Childbirth Publication. Read More
7 July 2016: Update: The EVERREST Team Supports Wider Inclusion of Pregnant Women in Clinical Trials Research. Read More
7 April 2016: Ultrasound in Obstetrics & Gynecology Publication – Press summary. Read More
9 March 2016: Free to access article published in Ultrasound in Obstetrics & Gynecology: Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction. Read More
10 November 2015: EVERREST prospective study data was presented at the Fetal Growth Conference in Barcelona. Read More
22 September 2015: The EVERREST team presented prospective study to Global Pregnancy Collaboration. Read More
05 June 2015: The EVERREST team supports wider inclusion of pregnant women in clinical trials research. Read More
10 March 2015: How can we improve growth of small babies before birth? Dr Anna David’s Lunch Hour Lecture is now on YouTube Read More
1 December 2014: Project Coordinator, Dr Anna David, interviewed by Pan European Networks, Science & Technology, about the EVERREST project's aims to provide maternal growth factor therapy to improve fetal growth. Read More
7 October 2014: EVERREST received a 'Go' decision from the EC. Read More
27 June 2014: The Queen Mary University of London Bioethics team submit to the EC a report on their interviews about the EVERREST project with women/couples affected by severe Fetal Growth Restriction. Read More
27 June 2014: The Queen Mary University of London Bioethics team add more data to their report on interviews about the EVERREST project with key stakeholders; the results do not change. Read More
19 May 2014: University of Lund hosts an effective meeting of the EVERREST project team. Read More
26 March 2014: First patient recruited to the EVERREST prospective study.
31 October 2013: The Queen Mary University of London Bioethics team submit to the EC a report on their interviews with key stakeholders about the EVERREST project. Read More
21 October 2013: Universitätsklinikum Hamburg-Eppendorf hosts a fruitful meeting of the EVERREST project team. Read More
24 May 2013: UCL hosts a successful meeting of the EVERREST project team. Read More
31 April 2013: Professor Richard Ashcroft, Queen Mary University of London, submits to the EC an in-depth literature review on the ethics of a clinical trial of growth factor therapy in pregnant women whose unborn babies are affected by FGR. Read More
31 January 2013: The EVERREST team kick-off meeting took place at UCL. Read More
23 January 2013: UCLH circulates a press release on the EVERREST project. Read More
17 January 2013: UCL circulates a press release on the EVERREST project. Read More